Current Frontline Treatment of Multiple Myeloma
Cancer Network,
ABSTRACT Treatment paradigms for management of newly diagnosed (ND) multiple myeloma have been evolving over the past 20 years…
Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarity
Overview of attention for article published in Blood Reviews, July 2020
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (81st percentile)
-
High Attention Score compared to outputs of the same age and source (82nd percentile)
Readers on
- mendeley
- 48 Mendeley